Substituted imidazoles as bombesin receptor subtype-3 modulators

Details for Australian Patent Application No. 2007309570 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Franklin, Christopher L.; Chen, David; Sebhat, Iyassu K.; Lo, Michael M.-C.; Guzzo, Peter R.; Nargund, Ravi P.; Lin, Linus S.

Agent Spruson & Ferguson

Pub. Number AU-B-2007309570

PCT Pub. Number WO2008/051406

Priority 60/853,193 20.10.06 US

Filing date 16 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 12 July 2012

International Classifications

C07D 401/10 Heterocyclic compounds containing two or more hetero rings

C07D 403/10 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/051406 Priority application(s): WO2008/051406

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

12 July 2012 Application Accepted

  Published as AU-B-2007309570

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309572-Compact padding attachments

2007309569-Substituted imidazoles as bombesin receptor subtype-3 modulators